Adverum Biotechnologies, Inc. (ADVM) Financials

ADVM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 173.0 million 89.5 million
2023-09-30 196.8 million 94.1 million
2023-06-30 241.4 million 110.3 million
2023-03-31 275.6 million 117.8 million

ADVM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -21.5 million 4.1 million
2023-09-30 -24.4 million 4.4 million
2023-06-30 -23.3 million 4.5 million
2023-03-31 -22.5 million 4.6 million

ADVM Net Income

No data available :(

ADVM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 75.0 million
2023-09-30 117.1 million - 75.5 million
2023-06-30 141.5 million - 91.2 million
2023-03-31 164.3 million - 97.6 million

ADVM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 101.0 million
2023-09-30 101.0 million
2023-06-30 100.8 million
2023-03-31 100.3 million

ADVM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 192000 15.3 million 10.9 million -
2023-09-30 495000 20.7 million 13.8 million -
2023-06-30 36000 20.6 million 12.5 million -
2023-03-31 85000 21.1 million 12.8 million -

ADVM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 1.5 million
2023-06-30 - 7.0 million
2023-03-31 3.6 million 3.0 million

ADVM

Price: $10

52 week price:
7.10
29.70

Earnings Per Share: -11.60 USD

P/E Ratio: -1.37

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 198800

Ebitda: -14.0 million

Market Capitalization: 248.5 million

Links: